A case of pancreatic cancer with formation of a mass mimicking alcoholic or autoimmune pancreatitis in a young man. Possibility of diagnosis by hypermethylation of pure pancreatic juice

Journal of the Pancreas

Volumn 9, Issue 1, 2008, Pages 37-45

  Ohtsubo, Koushiro ^a   Watanabe, Hiroyuki ^a   Okada, Gensaku ^a   Tsuchiyama, Tomoya ^a   Mouri, Hisatsugu ^a   Yamaguchi, Yasushi ^a   Motoo, Yoshiharu ^a   Okai, Takashi ^a   Amaya, Koji ^a   Kitagawa, Hirohisa ^a   Ohta, Tetsuo ^a   Gabata, Toshifumi ^a   Matsuda, Koichiro ^b   Ohta, Hideki ^b   Sawabu, Norio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b TONAMI GENERAL HOSPITAL   (Japan)

Author keywords

Alcoholic; Autoimmune diseases; Methylation; Pancreatic juice; Pancreatic neoplasms; Pancreatitis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DNA; FRIZZLED PROTEIN; GEMCITABINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; PLACENTA PROTEIN 5; PREDNISOLONE; PREPROENKEPHALIN;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLIC PANCREATITIS; ARTICLE; AUTOIMMUNE PANCREATITIS; CANCER MORTALITY; CASE REPORT; COMMON BILE DUCT STENOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DNA METHYLATION; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; MALE; PANCREAS BIOPSY; PANCREAS CANCER; PANCREAS DUCT STENOSIS; PANCREAS JUICE; PANCREATICODUODENECTOMY; PERCUTANEOUS BIOPSY; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; STEROID THERAPY; TUMOR GROWTH; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AUTOIMMUNE DISEASES; BIOPSY; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DIAGNOSIS, DIFFERENTIAL; DNA METHYLATION; FATAL OUTCOME; GLYCOPROTEINS; HUMANS; MALE; PANCREATIC JUICE; PANCREATIC NEOPLASMS; PANCREATITIS, ALCOHOLIC; ULTRASONOGRAPHY;

EID: 38349168093     PISSN: None     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Suda K, Takase M, Fukumura Y, Kashiwagi S. Pathology of autoimmune pancreatitis and tumor-forming pancreatitis. J Gastroenterol 2007; 42(Suppl 18):22-7.
2. Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas. An autonomous pancreatic disease? Am J Dig Dis 1961; 6: 688-98.
3. Toki F, Kozu T, Oi I, Nakasato T, Suzuki M, Hanyu F. An unusual type of chronic pancreatitis showing diffuse irregular narrowing of the entire main pancreatic duct on ERCP - A report of four cases. Endoscopy 1992; 24:640.
4. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995; 40:1561-8.
5. Pearson RK, Longnecker DS, Chari ST, Smyrk TC, Okazaki K, Frulloni L, Cavallini G. Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas 2003; 27:1-13.
6. Klöppel G, Lüttges J, Löhr M, Zamboni G, Longnecker D. Autoimmune pancreatitis: pathological, clinical, and immunological features. Pancreas 2003; 27:14-9.
7. Zamboni G, Luttges J, Capelli P, Frulloni L, Cavallini G, Pederzoli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004; 445:552-63.
8. Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, Nishimori I, et al. Clinical diagnostic criteria of autoinimune pancreatitis: revised proposal. J Gastroenterol 2006; 41:626-31.
9. Motoo Y, Minamoto T, Watanabe H, Sakai J, Okai T, Sawabu N. Sclerosing pancreatitis showing rapidly progressive changes with recurrent mass formation. Int J Pancreatol 1997; 21:85-90.
10. Servai: A, Pestieau SR, Detry O, Honoré P, Belaïche J, Boniver J, Jacquet N. Autoimmune pancreatitis mimicking cancer of the head of pancreas: report of two cases. Acta Gastroenterol Belg 2001; 64:227-30.
11. Pezzilli R, Casadei R, Calculli L, Santini D. Autoimmune pancreatitis. A - case mimicking carcinoma. JOP. J Pancreas (Online) 2004; 5:527-36.
12. Breuer A, Benz SR, Enz T, Deubler G, Mörk H. Autoinumme pancreatitis-a rare and difficult differential diagnosis to pancreatic cancer. Med Klin (Munich) 2007; 102:157-62.
13. Yamaguchi K, Chijiiwa K, Saiki S, Nakatsuka A, Tanaka M. 'Mass-forming' pancreatitis masquerades as pancreatic carcinoma. Int J Pancreatol 1996; 20:27-35.
14. Wakabayashi T, Kawaura Y, Satomura Y, Watanabe H, Motoo Y, Okai T, Sawabu N. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma. Am J Gastroenterol 2003; 98:2679-87.
15. Yamaguchi Y, Watanabe H, Yrdiran S, Ohtsubo K, Motoo Y, Okai T, Sawabu. N. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation. Clin Cancer Res 1999; 5:1147-53.
16. Ha A, Watanabe H, Yamaguchi Y, Ohtsubo K, Wang Y, Motoo Y, et al. Usefulness of supernatant of pancreatic juice for genetic analysis of K-ras in diagnosis of pancreatic carcinoma. Pancreas 2001; 23:356-63.
17. Wang Y, Yamaguchi X, Watanabe H, Ohtsubo K, Motoo Y, Sawabu N. Detection of p53 gene mutations in the supernatant of pancreatic juice and plasma from patients with pancreatic carcinomas. Pancreas 2004; 28:13-9.
18. Sawabu N, Watanabe H, Yamaguchi Y, Ohtsubo K, Motoo Y. Serum tumor markers and molecular biological diagnosis in pancreatic cancer. Pancreas 2004; 28:263-7.
19. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93:9821-6.
20. Ueki T, Toyota M, Skinner H, Walter KM, Yeo CJ, Issa JP, et al. Identification and characterization of differentially methylated. CpG islands in pancreatic carcinoma. Cancer Res 2001; 61:8540-6.
21. Fukushima N, Walter KM, Ueki T, Sato N, Matsubayashi H, Cameron JL, et al. Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice. Cancer Biol Ther 2003; 2:78-83.
22. Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, Cameron JL, et al. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res 2003; 63:3735-42.
23. Sato N, Parker AR, Fukushima N, Miyagi Y, Iacobuzio-Donahue CA, Eshleman JR, Goggins M. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. Oncogene 2005; 24:850-8.
24. Watanabe H, Okada G, Ohtsubo K, Yao F, Jiang PH, Mouri H, et al. Aberrant methylation of secreted apoptosis-related protein 2 (SARP2) in pure pancreatic juice in the diagnosis of pancreatic neoplasms. Pancreas 2006; 32:382-9.
25. Ohtsubo K, Watanabe H, Yao F, Okada G, Mouri H, Yamaguchi Y, Sawabu N. Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma. J Gastroenterol 2006; 41:791-7.
26. Jiang PH, Watanabe H, Okada G, Ohtsubo K, Mouri H, Tsuchiyama T, et al. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma. Cancer Sci 2006; 97:1267-73.
27. Sofuni A, lijima H, Moriyasu F, Nakayama D, Shimizu M, Nakamura K, et al. Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroenterol 2005; 40:518-25.
28. D'Onofrio M, Zamboni G, Tognolini A, Malago F, Faccioli N, Frulloni L, Pozzi Mucelli R. Mass-forming pancreatitis: value of contrast-enhanced ultrasonography. World J Gastroenterol 2006; 12:4181-4.
29. Tajima Y, Kuroki T, Tsutsumi R, Isomoto I, Uetani M, Kanematsu T. Pancreatic carcinoma coexisting with chronic pancreatitis versus tumor-forming pancreatitis: diagnostic utility of the time-signal intensity curve from dynamic contrast-enhanced MR imaging. World J Gastroenterol. 2007; 13:858-65.
30. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344:732-8.
31. Hirano K, Kawabe T, Yamamoto N, Nakai Y, Sasahira N, Tsujino T, et al. Serum IgG4 concentration in pancreatic and biliary diseases. Clin Chim Acta 2006; 367:181-4.
32. Ghazale A, Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007; 102:1646-53.
33. Choi EK, Kim MH, Lee TY, Kwon S, Oh HC, Hwang CY, et al. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas 2007; 35:156-61.
34. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Kamata N. Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Am J Gastroenterol 2003; 98:2694-9.
35. Spârchez; Z. Ultrasound-guided percutaneous pancreatic biopsy. Indications, performance and complications. Rom J Gastroenterol 2002; 11:335-41.
36. Pavlovskii AV, Granov DA, Ubranskii Al, Rasskazov AK, Tarazov PG. Percutaneous needle biopsy in the diagnosis of pancreatic cancer. Vopr Onkol 2003; 49:487-92.
37. Deshpande V, Mino-Kenudson M, Brugge WR, Pitman MB, Fernandez-del Castillo C, Warshaw AL, Lauwers GY. Endoscopic ultrasound guided fine needle aspiration biopsy of autoimmune pancreatitis: diagnostic criteria and pitfalls. Am J Surg Pathol 2005; 29:1464-71.
38. Khalid A, Nodit L, Zahid.M, Bauer K, Brody D, Finkelstein SD, McGrath KM. Endoscopic ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses. Am J Gastroenterol 2006; 101:2493-500.
39. Horwhat JD, Paulson EK, McGrath K, Branch MS, Baillie J, Tyler D, et al. A randomized comparison of EUS-guided FNA versus CT or US-guided FNA for the evaluation of pancreatic mass lesions. Gastrointest Endosc 2006; 63:966-75.
40. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986; 321:209-13.
41. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999; 21:163-7.
42. Ueki T, Toyota M, Sohn T, Yen CJ, Issa JP, Hruban RH, Goggins M. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 2000; 60:1835-9.
43. Gerdes B, Ramaswamy A, Ziegler A, Lang SA, Kersting M, Baumann R, et al. pl6INK4a is a prognostic marker in resected ductal pancreatic cancen: an analysis of pl6INK4a, p53, MDM2, an Rb. Ann Surg 2002; 235:51-9.
44. Ohtsubo K, Watanabe H, Yamaguchi Y, Hu YX, Motoo Y, Okai T, Sawabu N. Abnormalities of tumor suppressor gene p16 in pancreatic carcinoma: immunohistochemical and genetic findings compared with clinicopathological parameters. J Gastroenterol 2003; 38: 663-71.
45. Yamamoto H, Itoh F, Nakamura H, Fukushima H, Sasaki S, Perucho M, Imai K. Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability. Cancer Res 2001; 61:3139-44.
46. Dammann F, Schagdarsurengin U, Liu L, Otto N, Gimm O, Dralle H, et al. Frequent RASSF1 A promoter hypermethylation and K-ras mutations in pancreatic carcinoma. Oncogene 2003; 22:3806-12.
47. Matsumoto S, Harada H, Tanaka J, Ochi K, Seno T, Tsunimi T, Kunichika K. Evaluation of cytology and tumor markers of pure pancreatic juice for the diagnosis of pancreatic cancer at early stages. Pancreas 1994; 9:741-7.
48. Nakaizumi A, Uehara H, Takenaka, A, Uedo, N, Sakai N, Yano H, et al. Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy. Hepatogastroenterology 1999; 46:31-7.
49. Futakawa N, Kimura W, Yamagata S, Zhao B, IlsoO H, Inoue T, et al. Significance of K-ras mutation and CEA level in pancreatic juice in the diagnosis of pancreatic cancer. J Hepatobiliary Pancreat Surg 2000; 7: 63-71.
50. Ohta H, Sawabu N, Takemori Y, Kidani H, Wakabayashi T, Satomura Y, et al. Measurement of sialylated stage-specific embryonic antigen-1 in pure pancreatic juice for the diagnosis of pancreatic cancer. Int J Pancreatol 1994; 15:35-41.
51. Takemori Y, Sawabu N, Ohta H, Satomura Y, Watanabe H, Yamakawa O, et al. Evaluation of Cancer-Associated Carbohydrate Antigen (NCC-ST-439) Measurement in Pure Pancreatic Juice Collected by Endoscopic Aspiration. Dig Endosc 1990; 2:141-7.
52. Tabata M, Kitayama J, Kanemoto H, Fukasawa, T, Goto H, Taniwaka K. Autoimmune pancreatitis presenting as a mass in the head of the pancreas: a diagnosis to differentiate from cancer. Am Surg 2003; 69:363-6.
53. Knezević D. Suppression of tumor immunity by electromagnetic fields and glucocorticoids in mice with implanted Ehrlich carcinoma. Med Pregl 2005; 58: 609-13.